Biotechnology · San Francisco, CA · Founded 2018 · Privately Held (backing)
Developer of antibody-based therapeutics designed to treat serious and underserved diseases through novel biological pathways. Star Therapeutics is based in San Francisco, CA and was founded in 2018. It has raised $315 million across 3 recorded rounds; the latest was a $125 million Series D in Sep 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$315.0M
Last round
Later Stage VC (Series D)
Sep 2025
Team — not yet on record
No current team members for Star Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Star Therapeutics with a free account
·The complete investor list: 19 names
·Watch Star Therapeutics: the Monday email on marks, rounds and moves
